We further verified the protein levels of TIM in 176 OV samples from several hospitals by immunohistochemical (IHC) analysis, and the results showed that the protein levels of TIM were upregulated in different types of ovarian cancer compared to benign tumors (Figure 1D). The gene discussed is TIMELESS; the disease is ovarian carcinoma.